Delivery Order SPE2DB20D2104-SPE2DB24FU85P
Award Date
6/24/24
Potential Completion Date
6/25/24
Potential Value
$7.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $6,214.49, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of 4,566,416,987 units of Losartan Potassium 100 mg tablets, a cardiovascular medication, with a completion date of November 7, 2024.
The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,678.42 firm fixed-price delivery order is for the supply of 50 mg Losartan Potassium tablets, a medication used to treat high blood pressure and heart failure.
The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which...
This federal contract award, valued at $1,433.58, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Losartan Potassium 50 mg tablets in quantities of 1,000 per bottle. The contract has an ultimate completion date of January 16, 2025 and is a Firm Fixed Price Delivery Order. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award, valued at $1,743.39, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,555,540,832 units of Losartan Potassium 100 mg tablets, with an ultimate completion date of November 30, 2021.
The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,198.25 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of 50 mg Losartan Potassium tablets. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide 1,000 units of Losartan Potassium 50 mg tablets. The firm-fixed-price delivery order, valued at $9,937.89, has an ultimate completion date of August 29, 2022.
Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,249.22 firm fixed-price delivery order is for the supply of 4,566,693 units of Losartan Potassium 100 mg tablets. The contract has an ultimate completion date of December 12, 2024 and was awarded on December 11, 2024. This award appears to be part of a larger $999,999,999 Indefinite...
This federal contract award, valued at $1,754.26, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,373,891 units of Losartan Potassium 25mg tablets. The contract has an ultimate completion date of November 8, 2024 and is a firm-fixed-price delivery order. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Losartan Potassium 100 mg tablets. The contract has a ceiling value of $3,473.52 and is a delivery order with a firm fixed price. The contract has an ultimate completion date of September 10, 2024. This award does not utilize any set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,495.76 firm fixed-price delivery order is for the supply of 4,566,599 units of Losartan Potassium 100 mg tablets. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...